Another study demonstrated that elevated GLI1 expression in head and neck squamous cell carcinoma is enhanced by RT, leading to therapy resistance (Chaudary et al., 2017; Zhang et al., 2021). The gene discussed is GLI1; the disease is head and neck squamous cell carcinoma.